The Japanese electronics giant, which is deeply mired in mudslides, has to face the task of finding new profit growth points while the traditional industry market is shrinking. The medical device market is one of its main directions.
On April 16, Sony and Olympus jointly announced the establishment of Sony Olympus Medical Solutions. The new company has a registered capital of 50 million yen, 51% owned by Sony, and 49% owned by Olympus. It aims to integrate Sony's technology in electronic fields such as digital imaging with Olympus lens optics and its medical products. Experience in manufacturing and R&D in the field, research, design, production and marketing of innovative medical products.
Coincidentally, at the 69th China International Medical Equipment Fair (CMEF) held in Shenzhen on April 17-19, Japanese traditional electronic giant medical system products such as Canon, Panasonic and Fujifilm unveiled innovative medical products.
"Sony and Olympus entered the medical market precisely because of the limited growth space of traditional electronic business, while the medical field has a growing market space." A Shenzhen analyst familiar with the global medical market told this newspaper.
On April 17th at CMEF, a minister of Matsushita Health Medical Devices Co., Ltd. said that Matsushita may sell part of the medical business to introduce new cooperative investors.
At the same time, Fujifilm Medical Systems launched four X-ray digital flat-panel systems, a new HD endoscope processing system in China, and a portable color ultrasound developed by the newly acquired company Sonoma. Fujifilm (China) Investment Co., Ltd., Vice President and Head of the Medical Business Division, Mr. Ota Yasuhiro, said that Fujifilm Medical Systems will continue to expand its business in China in the next few years, focusing on the development of new products for the detection of lesions and disease treatment. Promotion. According to public information, Fujifilm's total sales in fiscal year 2011 was approximately US$27.79 billion, and its operating profit was approximately US$1.43 billion. The medical and health business accounted for 13.2% of revenue.
From 2001 to 2009, global medical device market sales increased from $187 billion to $355.3 billion, with a compound growth rate of 8.35%. In 2012, China's medical device market was about 150 billion yuan, with a compound growth rate of 21.3% in the past 10 years.
The above analysts pointed out that compared with European and American medical device giants, Japan's electronic and image processing technology is leading the world, which also laid the core advantages of Japanese traditional electronics giants in medical diagnosis and medical imaging.
Desly Foods Co.,Ltd. , https://www.deslygroup.com